Candice L Willmon
Overview
Explore the profile of Candice L Willmon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
88
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Morgans A, Sonpavde G, Shih V, Wright P, Hepp Z, Willmon C, et al.
Clin Genitourin Cancer
. 2024 Dec;
23(1):102270.
PMID: 39662152
Introduction: 1L PBC has historically been recommended for patients with la/mUC. Maintenance avelumab is recommended for patients without disease progression following 1L PBC. Real-world data on the proportion of patients...
2.
Morgans A, Galsky M, Wright P, Hepp Z, Chang N, Willmon C, et al.
Urol Oncol
. 2023 May;
41(8):357.e11-357.e21.
PMID: 37208230
Introduction: Patients with locally advanced/metastatic urothelial carcinoma (la/mUC) have a poor prognosis. With recent therapeutic advances, data on real-world treatment patterns and overall survival (OS) in patients with la/mUC treated...
3.
Willmon C, Saloura V, Fridlender Z, Wongthida P, Diaz R, Thompson J, et al.
Cancer Res
. 2009 Sep;
69(19):7713-20.
PMID: 19773437
Our preclinical and clinical trials using a replication-defective adenoviral vector expressing IFN-beta have shown promising results for the treatment of malignant mesothelioma. Based on the hypotheses that a replication-competent vesicular...
4.
Stolworthy T, Korkegian A, Willmon C, Ardiani A, Cundiff J, Stoddard B, et al.
J Mol Biol
. 2008 Feb;
377(3):854-69.
PMID: 18291415
Prodrug gene therapy (PGT) is a treatment strategy in which tumor cells are transfected with a 'suicide' gene that encodes a metabolic enzyme capable of converting a nontoxic prodrug into...